Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Peringkat dalam Saham #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Harga Saham
$29.06
Terakhir disinkronkan: 2023-02-23
Kapitalisasi Pasar
$682.73M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan CinCor Pharma, Inc. (CINC)

Kategori

Riwayat harga saham CinCor Pharma, Inc. (CINC)
Harga penutupan tertinggi: $29.26 pada 2023-02-01

Harga penutupan terendah: $16.50 pada 2022-01-01
Riwayat harga saham CinCor Pharma, Inc. dari 2022 hingga 2026
Performa harga saham tahunan
Tahun Performa
2023 146.11%
2022 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH